Puma Biotechnology, Inc.PBYINASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank50
3Y CAGR-17.1%
5Y CAGR-14.0%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-17.1%/yr
vs +1.3%/yr prior
5Y CAGR
-14.0%/yr
Recent deceleration
Acceleration
-18.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$6.60M-47.0%
2024$12.45M-6.6%
2023$13.33M+15.0%
2022$11.59M-9.5%
2021$12.81M-8.8%
2020$14.05M-6.4%
2019$15.00M+36.4%
2018$11.00M+1427.8%
2017$720000.00-24.8%
2016$958000.00-